Loading…
Dyadic International, Inc. is projected to rise to $1.44 by 2027, a +36% move from its current price of $1.06. DYAI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.00 | $1.06 | $1.12 | -0.16% |
| Jul 13 | $0.9775 | $1.06 | $1.14 | -0.32% |
| Jul 14 | $0.959 | $1.05 | $1.16 | -0.48% |
| Jul 15 | $0.9435 | $1.05 | $1.18 | -0.64% |
| Jul 16 | $0.9298 | $1.05 | $1.19 | -0.80% |
| Jul 17 | $0.9174 | $1.05 | $1.20 | -0.96% |
| Jul 18 | $0.9061 | $1.05 | $1.21 | -1.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9061 | $1.05 | $1.21 | -1.12% |
| Week 2 | $0.8435 | $1.04 | $1.27 | -2.23% |
| Week 3 | $0.7964 | $1.02 | $1.32 | -3.33% |
| Week 4 | $0.7573 | $1.01 | $1.36 | -4.41% |
| Week 5 | $0.7235 | $1.00 | $1.39 | -5.49% |
| Week 6 | $0.6935 | $0.9906 | $1.41 | -6.55% |
| Week 7 | $0.6664 | $0.9795 | $1.44 | -7.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dyadic International, Inc., together with its subsidiaries, is a biotechnology platform company that develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins.
It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
DYAI is currently trading at $1.06 and has a market cap of $38.63M.
The stock is ranked 4682. The price outlook is bullish over the longer horizon, with the average forecast price rising from $1.06 in 2026 to $12.81 in 2050 and the maximum forecast price reaching $29.46 by 2050.
For near-term context, the forecast shows a 2026 average of $1.06, with a 2026 min of $0.68 and a 2026 max of $1.33. The model projects notable upside by 2030, with an average of $2.61 and a max of $4.52, yielding a 145.8 ROI. By 2050, the average price is projected at $12.81 with a max of $29.46 and an extraordinary 1108.2 ROI.
A major floor 48.4% below — a decisive break under it would weaken the trend.
The nearest floor, 35.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 25.2% above — clearing it would confirm fresh momentum.
Key DYAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DYAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.03 | Buy | $1.03 | Buy |
| MA 10 | $0.97 | Buy | $0.9748 | Buy |
| MA 20 | $0.8665 | Buy | $0.9034 | Buy |
| MA 50 | $0.789 | Buy | $0.8359 | Buy |
| MA 100 | $0.8061 | Buy | $0.8331 | Buy |
| MA 200 | $0.8938 | Buy | $0.8887 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.72 | Neutral |
| Stoch RSI (14) | 78.04 | Neutral |
| CCI (20) | 117.11 | Buy |
| Williams %R (14) | -2.94 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 30.86 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 97.06 | Sell |
| TRIX (15) | 0.98 | Buy |
| Awesome (5,34) | 0.22 | Buy |
| Ultimate (7,14,28) | 66.71 | Neutral |
| Momentum (10) | 0.32 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 1.07 | Sell |
| ADX (14) | 19.79 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish. The RSI(14) stands at 70, indicating strong momentum near overbought territory. The sentiment is labeled BULLISH, with the 50-day simple moving average at $0.7762 and the 200-day simple moving average at $0.8936, both below the current price of $1.06.
Key near-term levels include a support at $0.68 and a resistance at $1.06. The thirty-day range spans from a low of $0.7269 to a high of $1.55, highlighting upside potential within a tight range around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.68 | $1.06 | $1.35 | 0% | Neutral | |
| $1.05 | $1.44 | $2.15 | +36% | Bullish | |
| $1.42 | $2.07 | $3.30 | +96% | Bullish | |
| $1.42 | $2.19 | $3.65 | +107% | Bullish | |
| $1.70 | $2.75 | $4.78 | +160% | Bullish | |
| $1.69 | $2.85 | $5.12 | +169% | Bullish | |
| $1.42 | $2.51 | $4.64 | +136% | Bullish | |
| $1.57 | $2.89 | $5.50 | +173% | Bullish | |
| $1.78 | $3.40 | $6.64 | +221% | Bullish | |
| $2.37 | $4.70 | $9.38 | +343% | Bullish | |
| $2.43 | $5.40 | $11.86 | +410% | Bullish | |
| $6.79 | $15.10 | $34.73 | +13.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.68 | $1.06 | $1.30 | +0.00% |
| August 2026 | $0.7943 | $0.9626 | $1.22 | -9.19% |
| September 2026 | $0.7446 | $0.915 | $1.18 | -4.94% |
| October 2026 | $0.7991 | $0.994 | $1.30 | +8.63% |
| November 2026 | $0.818 | $1.03 | $1.37 | +3.43% |
| December 2026 | $0.7881 | $1.00 | $1.35 | -2.71% |
Click any year to see its month-by-month DYAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DYAI price prediction for 2026 points to an average of $1.06 (low $0.68, high $1.35) — a potential gain of 0% on today's $1.06. Price action looks broadly range-bound.
In 2027, DYAI is projected to trade between $1.05 and $2.15, averaging $1.44 — a potential gain of +36% from today's $1.06. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Dyadic International, Inc.'s 2028 outlook centres on $2.07, within a $1.42 to $3.30 range. That is up +44% on the projected 2027 average. That marks a +96% change versus current levels. Momentum favours further upside here.
By 2029, DYAI could reach as high as $3.65, with a base case around $2.19 and support toward $1.42 — roughly +107% from $1.06. Buyers look set to stay in control over this stretch.
Expect DYAI to range from $1.70 to $4.78 through 2030. The $2.75 average target implies a +160% move from current prices. That is up +26% on the projected 2029 average. Momentum favours further upside here.
The DYAI price prediction for 2031 points to an average of $2.85 (low $1.69, high $5.12) — a potential gain of +169% on today's $1.06. Buyers look set to stay in control over this stretch.
In 2032, DYAI is projected to trade between $1.42 and $4.64, averaging $2.51 — a potential gain of +136% from today's $1.06. That is -12% versus the projected 2031 average. Momentum favours further upside here.
Dyadic International, Inc.'s 2033 outlook centres on $2.89, within a $1.57 to $5.50 range. That is up +15% on the projected 2032 average. That marks a +173% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, DYAI could reach as high as $6.64, with a base case around $3.40 and support toward $1.78 — roughly +221% from $1.06. Momentum favours further upside here.
Expect DYAI to range from $2.37 to $9.38 through 2035. The $4.70 average target implies a +343% move from current prices. That is up +38% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DYAI price prediction for 2040 points to an average of $5.40 (low $2.43, high $11.86) — a potential gain of +410% on today's $1.06. Momentum favours further upside here.
In 2050, DYAI is projected to trade between $6.79 and $34.73, averaging $15.10 — a potential gain of +13.2x from today's $1.06. That is up +179% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DYAI today (≈ 943.396226 DYAI) could be worth
$14,244.85
+$13,244.85 (+1324%) by 2050 · US Dollar
Based on the average projected DYAI price of $15.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DYAIwould be worth at today's price.
$1,000 invested in DYAI on Jul 10, 2025 (≈ 1,000 DYAI) would be worth
$1,060
+$60 (+6.0%) today · 1.06× · US Dollar
Based on a DYAI entry price of $1 vs. today's $1.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.94 | $1,127.66 | +12.8% |
| 1 month ago | $0.73 | $1,452.05 | +45.2% |
| 3 months ago | $0.89 | $1,191.01 | +19.1% |
| 6 months ago | $0.93 | $1,139.78 | +14.0% |
| 1 year ago | $1 | $1,060 | +6.0% |
| All time (5.0y) ago | $3.61 | $293.63 | -70.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DYAI forecast.
Our base-case forecast reaches $2.10 around 2029.
Implied market cap at $2.10: $76.52M
The multi-year forecast shows a sustained bullish trajectory, with the 2030 average price at $2.61 and a max of $4.52, translating to a 145.8 ROI, and the 2040 average at $4.60 with a 333.8 ROI. By 2050, the forecast envisions an average price of $12.81 and a max of $29.46, corresponding to an 1108.2 ROI. These figures suggest meaningful upside potential over the decade and a half to mid-century, albeit as estimates with inherent uncertainty.
Drivers of the longer-term outlook include expansion of protein production platforms and ongoing collaborations and licensing activity. Risks include the inherent volatility of small-cap names and execution-related uncertainties, which can affect forecast accuracy. These figures are not guarantees, but they outline a path of potential appreciation under varying market conditions.
Tap a question to reveal the answer.
Avg $2.61, min $1.61, max $4.52, ROI 145.8, sentiment BULLISH.
Forecasts show bullish sentiment across multiple years with rising averages and positive ROI (e.g., 2027 avg $1.39 with 31.5 ROI, 2030 avg $2.61 with 145.8 ROI, 2050 avg $12.81 with 1108.2 ROI). These are estimates, not guarantees.
Yes. The 2030 max is $4.52 and the 2031 max is $4.75, with earlier years showing max values up to $5.00 (2033) and $5.85 (2034).
Current price is $1.06 and market cap is $38.63M.
Sentiment is BULLISH with RSI(14) at 70. SMA50 is $0.7762, SMA200 is $0.8936. Support sits at $0.68 and resistance at $1.06; the 30-day range is $0.7269 to $1.55.
Dyadic International, Inc. Community Discussion
0Share your Dyadic International, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.